Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Meningococcal Conjugate Vaccine market report explains the definition, types, applications, major countries, and major players of the Meningococcal Conjugate Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Pfizer
GlaxoSmithKline
Sanofi
By Type:
Menactra
MENVEO
By End-User:
Children
Adults
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Meningococcal Conjugate Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Meningococcal Conjugate Vaccine Outlook to 2028- Original Forecasts
-
2.2 Meningococcal Conjugate Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Meningococcal Conjugate Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Meningococcal Conjugate Vaccine Market- Recent Developments
-
6.1 Meningococcal Conjugate Vaccine Market News and Developments
-
6.2 Meningococcal Conjugate Vaccine Market Deals Landscape
7 Meningococcal Conjugate Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Meningococcal Conjugate Vaccine Key Raw Materials
-
7.2 Meningococcal Conjugate Vaccine Price Trend of Key Raw Materials
-
7.3 Meningococcal Conjugate Vaccine Key Suppliers of Raw Materials
-
7.4 Meningococcal Conjugate Vaccine Market Concentration Rate of Raw Materials
-
7.5 Meningococcal Conjugate Vaccine Cost Structure Analysis
-
7.5.1 Meningococcal Conjugate Vaccine Raw Materials Analysis
-
7.5.2 Meningococcal Conjugate Vaccine Labor Cost Analysis
-
7.5.3 Meningococcal Conjugate Vaccine Manufacturing Expenses Analysis
8 Global Meningococcal Conjugate Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Meningococcal Conjugate Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Meningococcal Conjugate Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Meningococcal Conjugate Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Meningococcal Conjugate Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Menactra Consumption and Growth Rate (2017-2022)
-
9.1.2 Global MENVEO Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningococcal Conjugate Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Children Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adults Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Meningococcal Conjugate Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.2.2 Canada Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.2 UK Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.3 Spain Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.5 France Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.6 Italy Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.8 Finland Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.9 Norway Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.11 Poland Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.12 Russia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.2 Japan Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.3 India Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.3 Chile Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.6 Peru Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6.3 Oman Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Meningococcal Conjugate Vaccine Consumption (2017-2022)
11 Global Meningococcal Conjugate Vaccine Competitive Analysis
-
11.1 Pfizer
-
11.1.1 Pfizer Company Details
-
11.1.2 Pfizer Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Pfizer Meningococcal Conjugate Vaccine Main Business and Markets Served
-
11.1.4 Pfizer Meningococcal Conjugate Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Company Details
-
11.2.2 GlaxoSmithKline Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 GlaxoSmithKline Meningococcal Conjugate Vaccine Main Business and Markets Served
-
11.2.4 GlaxoSmithKline Meningococcal Conjugate Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sanofi
-
11.3.1 Sanofi Company Details
-
11.3.2 Sanofi Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sanofi Meningococcal Conjugate Vaccine Main Business and Markets Served
-
11.3.4 Sanofi Meningococcal Conjugate Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
12 Global Meningococcal Conjugate Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global MENVEO Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Meningococcal Conjugate Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Meningococcal Conjugate Vaccine
-
Figure of Meningococcal Conjugate Vaccine Picture
-
Table Global Meningococcal Conjugate Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Meningococcal Conjugate Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Menactra Consumption and Growth Rate (2017-2022)
-
Figure Global MENVEO Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Table North America Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure United States Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure Germany Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure China Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure Australia Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table Pfizer Company Details
-
Table Pfizer Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Meningococcal Conjugate Vaccine Main Business and Markets Served
-
Table Pfizer Meningococcal Conjugate Vaccine Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Meningococcal Conjugate Vaccine Main Business and Markets Served
-
Table GlaxoSmithKline Meningococcal Conjugate Vaccine Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Meningococcal Conjugate Vaccine Main Business and Markets Served
-
Table Sanofi Meningococcal Conjugate Vaccine Product Portfolio
-
Figure Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MENVEO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
